[On meningoencephalitis caused by Cryptococcus neoformans. Diagnostic and therapeutic study].
D000666:Amphotericin B / Q000008:administration & dosage*; D000935:Antifungal Agents / Q000008:administration & dosage*; D001241:Aspirin / Q000627:therapeutic use; D003168:Complement Fixation Tests; D003453:Cryptococcosis / Q000150:complications*; D003454:Cryptococcus / Q000145:classification / Q000302:isolation & purification*; D003455:Cryptococcus neoformans / Q000302:isolation & purification; D003596:Cytosine / Q000627:therapeutic use; D005260:Female; D005455:Fluorescent Antibody Technique; D005461:Fluorine / Q000627:therapeutic use; D006386:Hemagglutination Tests; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D008590:Meningoencephalitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D008875:Middle Aged
D000935:Antifungal Agents; D006634:Histamine H1 Antagonists; D005461:Fluorine; D000666:Amphotericin B; D003596:Cytosine; D001241:Aspirin
Di una meningo-encefalite da Cryptococcus neoformans. Contributo diagnostico e terapeutico.